Australia Health

Biome Australia (ASX:BIO) has cleared the final regulatory hurdle to begin a landmark human clinical trial for its proprietary probiotic strain, Lactobacillus plantarum BMB18.

Medical technology innovator OncoSil Medical (ASX:OSL) announced a comprehensive $8 million capital raising initiative.

Ryman Healthcare (ASX:RYM), the trans-Tasman leader in retirement living, announced a sweeping strategic overhaul and a new capital management framework aimed at unlocking value from its $12 billion portfolio.

Telix Pharmaceuticals (ASX:TLX) announced the immediate resignation of board Chair and Non-Executive Director Tiffany Olson.

Rhythm Biosciences (ASX:RHY) has reached a pivotal commercial milestone by executing a multi-year supply agreement with US-based Quansys Biosciences.

Neuren Pharmaceuticals (ASX:NEU) shares plummeted as much as 22% on Feb. 3 morning, following a major regulatory hurdle for its flagship Rett syndrome treatment, trofinetide.

Clinical-stage biopharmaceutical firm Neurotech International (ASX:NTI) has reached a transformative regulatory milestone, receiving Human Research Ethics Committee approval to commence its Beyond Harmony Phase 3 clinical study.

Microbiome health specialist Biome Australia (ASX:BIO) has bolstered its North American presence by entering into a distribution partnership with Fullscript.

PYC Therapeutics (ASX:PYC) has launched a "monster" $653 million equity raising aimed at propelling its rare genetic disease portfolio through 2030.

Memphasys (ASX:MEM) announced a breakthrough in its Middle East expansion, securing its first major institutional reference customer in the region.

Synthetic anti-infectives biotech Recce Pharmaceuticals (ASX:RCE) has entered into a Cooperative Research and Development Agreement with the US Army Institute of Surgical Research.

OncoSil Medical (ASX:OSL) announced early clinical results from Ankara Bilkent City Hospital in Türkiye, demonstrating a potential paradigm shift in the treatment of unresectable locally advanced pancreatic cancer.